doi: 10.3389/fphar.2023.1226778 Received 22 May 2023 Accepted 31 July 2023 Published 09 August 2023 Volume 14 - 2023 Edited by Tomoya Tachi, Nagoya City University, Japan Reviewed by Yu Kondo, Toyota Kosei Hospital, Japan Richard Pratley, AdventHealth, United States Updates Copyright 2023 Feng, Tong, Zhang and Tang
Since this discovery, GLP-1 receptors have been identified in a number of tissues, including the GI tract, pancreas, brain, lung, and kidney
Safety and emerging outcome studies
The clinical toxicology of caffeine: A review and case study
preparation outside this setting is unsafe and unlawful in the UK
These trials assess the impact of the medication on cardiovascular events, providing valuable information on the safety and potential cardiovascular benefits of the drug